Unique Use of Alkylation for Chemo-Redox Activity by a PtIV Prodrug

Rakesh K. Pathak, Shanta Dhar

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Resistance towards chemotherapeutics displayed by cancer cells is a significant stumbling block against fruitful cisplatin-based therapy. A unique dual-acting chemotherapeutic modality, Platin-B, a prodrug of cisplatin and pipobroman-mimicking alkylating agent, was constructed to circumvent tumor resistance. Platin-B exhibited a superior cytotoxicity profile in cisplatin-resistant cancer cells. Enhanced activity and the ability to overcome cancer-induced resistance of Platin-B was related to adduct formation with intracellular glutathione, followed by the activity of Platin-B on the mitochondria of cells, along with its conventional nuclear activity. Alkylating moieties present on Platin-B enhanced its cellular and subcellular concentration and protected it from early drug sequestration by biological thiols. A unique dual-acting chemotherapeutic modality Platin-B, a prodrug of PtIV and pipobroman-mimicking alkylating agent, was constructed to act on the mitochondria of cells by using its pendent -Br moieties to induce changes in mitochondrial bioenergetics, formation of repair-inactive Pt-DNA adducts, and ultimately participation in mitochondrial apoptosis and loss of mitochondrial mass to overcome resistance compared to other similar Pt-based compounds.

Original languageEnglish (US)
Pages (from-to)3029-3036
Number of pages8
JournalChemistry - A European Journal
Volume22
Issue number9
DOIs
StatePublished - Feb 24 2016
Externally publishedYes

Fingerprint

Pipobroman
Mitochondria
Alkylation
Prodrugs
Cisplatin
Alkylating Agents
Cells
Cell death
Cytotoxicity
Tumors
Repair
DNA Adducts
Sulfhydryl Compounds
Glutathione
Apoptosis
Pharmaceutical Preparations
Oxidation-Reduction
Energy Metabolism

Keywords

  • alkylating agent
  • cancer
  • cisplatin
  • DNA repair
  • glutathione

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Unique Use of Alkylation for Chemo-Redox Activity by a PtIV Prodrug. / Pathak, Rakesh K.; Dhar, Shanta.

In: Chemistry - A European Journal, Vol. 22, No. 9, 24.02.2016, p. 3029-3036.

Research output: Contribution to journalArticle

@article{f66f4f011c404ec98dbb982d420d6ae2,
title = "Unique Use of Alkylation for Chemo-Redox Activity by a PtIV Prodrug",
abstract = "Resistance towards chemotherapeutics displayed by cancer cells is a significant stumbling block against fruitful cisplatin-based therapy. A unique dual-acting chemotherapeutic modality, Platin-B, a prodrug of cisplatin and pipobroman-mimicking alkylating agent, was constructed to circumvent tumor resistance. Platin-B exhibited a superior cytotoxicity profile in cisplatin-resistant cancer cells. Enhanced activity and the ability to overcome cancer-induced resistance of Platin-B was related to adduct formation with intracellular glutathione, followed by the activity of Platin-B on the mitochondria of cells, along with its conventional nuclear activity. Alkylating moieties present on Platin-B enhanced its cellular and subcellular concentration and protected it from early drug sequestration by biological thiols. A unique dual-acting chemotherapeutic modality Platin-B, a prodrug of PtIV and pipobroman-mimicking alkylating agent, was constructed to act on the mitochondria of cells by using its pendent -Br moieties to induce changes in mitochondrial bioenergetics, formation of repair-inactive Pt-DNA adducts, and ultimately participation in mitochondrial apoptosis and loss of mitochondrial mass to overcome resistance compared to other similar Pt-based compounds.",
keywords = "alkylating agent, cancer, cisplatin, DNA repair, glutathione",
author = "Pathak, {Rakesh K.} and Shanta Dhar",
year = "2016",
month = "2",
day = "24",
doi = "10.1002/chem.201503866",
language = "English (US)",
volume = "22",
pages = "3029--3036",
journal = "Chemistry - A European Journal",
issn = "0947-6539",
publisher = "Wiley-VCH Verlag",
number = "9",

}

TY - JOUR

T1 - Unique Use of Alkylation for Chemo-Redox Activity by a PtIV Prodrug

AU - Pathak, Rakesh K.

AU - Dhar, Shanta

PY - 2016/2/24

Y1 - 2016/2/24

N2 - Resistance towards chemotherapeutics displayed by cancer cells is a significant stumbling block against fruitful cisplatin-based therapy. A unique dual-acting chemotherapeutic modality, Platin-B, a prodrug of cisplatin and pipobroman-mimicking alkylating agent, was constructed to circumvent tumor resistance. Platin-B exhibited a superior cytotoxicity profile in cisplatin-resistant cancer cells. Enhanced activity and the ability to overcome cancer-induced resistance of Platin-B was related to adduct formation with intracellular glutathione, followed by the activity of Platin-B on the mitochondria of cells, along with its conventional nuclear activity. Alkylating moieties present on Platin-B enhanced its cellular and subcellular concentration and protected it from early drug sequestration by biological thiols. A unique dual-acting chemotherapeutic modality Platin-B, a prodrug of PtIV and pipobroman-mimicking alkylating agent, was constructed to act on the mitochondria of cells by using its pendent -Br moieties to induce changes in mitochondrial bioenergetics, formation of repair-inactive Pt-DNA adducts, and ultimately participation in mitochondrial apoptosis and loss of mitochondrial mass to overcome resistance compared to other similar Pt-based compounds.

AB - Resistance towards chemotherapeutics displayed by cancer cells is a significant stumbling block against fruitful cisplatin-based therapy. A unique dual-acting chemotherapeutic modality, Platin-B, a prodrug of cisplatin and pipobroman-mimicking alkylating agent, was constructed to circumvent tumor resistance. Platin-B exhibited a superior cytotoxicity profile in cisplatin-resistant cancer cells. Enhanced activity and the ability to overcome cancer-induced resistance of Platin-B was related to adduct formation with intracellular glutathione, followed by the activity of Platin-B on the mitochondria of cells, along with its conventional nuclear activity. Alkylating moieties present on Platin-B enhanced its cellular and subcellular concentration and protected it from early drug sequestration by biological thiols. A unique dual-acting chemotherapeutic modality Platin-B, a prodrug of PtIV and pipobroman-mimicking alkylating agent, was constructed to act on the mitochondria of cells by using its pendent -Br moieties to induce changes in mitochondrial bioenergetics, formation of repair-inactive Pt-DNA adducts, and ultimately participation in mitochondrial apoptosis and loss of mitochondrial mass to overcome resistance compared to other similar Pt-based compounds.

KW - alkylating agent

KW - cancer

KW - cisplatin

KW - DNA repair

KW - glutathione

UR - http://www.scopus.com/inward/record.url?scp=84962600931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962600931&partnerID=8YFLogxK

U2 - 10.1002/chem.201503866

DO - 10.1002/chem.201503866

M3 - Article

C2 - 25043175

AN - SCOPUS:84962600931

VL - 22

SP - 3029

EP - 3036

JO - Chemistry - A European Journal

JF - Chemistry - A European Journal

SN - 0947-6539

IS - 9

ER -